The emerging therapy of tirzepatide peptide represents a major advance in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide518687.therainblog.com/40486240/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment